US 6664227
Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
expired A61KA61K38/00A61P
Quick answer
US patent 6664227 (Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Dec 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Dec 16 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K38/00, A61P, A61P1/00, A61P1/16